Clasificaciones en Gastroenterología Referencias 1.- Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol 2016; 111: 30-50. 2.- Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63: 7-42. 3.- El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal refl ux disease: a systematic review. Gut 2014; 63: 871-80. 4.- Edison E, Agha RA, Camm CF. Norman Barrett (1903-79): unorthodox pioneer of thoracic and oesophageal surgery. J Med Biogr 2013; 21: 64-9. 5.- ASGE Technology Committee, Thosani N, Abu Dayyeh BK, Sharma P, Aslanian HR, Enestvedt BK, et al. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett’s esophagus. Gastrointest Endosc 2016; 83: 684-98. 6.- Das D, Ishaq S, Harrison R, Kosuri K, Harper E, Decaestecer J, et al. Management of Barrett’s esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol 2008; 103: 1079-89. 7.- Abrams JA, Kapel RC, Lindberg GM, Saboorian MH, Genta RM, Neugut AI, et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009; 7: 736-42. 8.- Qumseya BJ, Wang H, Badie N, 186 Clasificaci one s para eva luaci ón de Esófag o de Barrett - P. Calderón D. et al. Uzomba RN, Parasa S, White DL, et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett’s esophagus: a metaanalysis and systematic review. Clin Gastroenterol Hepatol 2013; 11: 1562-70. 9.- Mannath J, Subramanian V, Hawkey CJ, Ragunath K. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Endoscopy 2010; 42: 351-9. 10.- Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Shama P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc 2012; 76: 531-8. 11.- Pech O, Gossner L, Manner H, May A, Rabenstein T, Behrens A, et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy 2007; 39: 588-93. 12.- Kariyawasam VC, Bourke MJ, Hourigan LF, Lim G, Moss A, Williams SJ, et al. Circumferential locations predicts the risk of high-grade dysplasia and early adenocarcinoma in short segment Barrett’s esophagus. Gastrointest Endosc 2012; 75: 938-44. 13.- Cassani L, Sumner E, Slaughter JC, Yachimiski P. Directional distribution of neoplasia in Barrett’s esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc 2013; 77: 877-82. 14.- Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol 2011; 106: 1447-55. 15.- Byrne JP, Bhatnagar S, Hamid B, Armstrong GR, Altwood SE. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy. Am J Gastroenterol 1999; 94: 98-103. 16.- Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett’s esophagus. Dig Dis Sci 1997; 42: 597-602. 17.- Zaninotto G, Avellini C, Barbazza R, Baruchello G, Battaglia G, Benedetti E, et al. Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in northeast Italy: a prospective, descriptive survey. The Italian Ulcer Study Group “GISU”. Dig Liver Dis 2001; 33: 316-21. 18.- Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-9. 19.- Vahabzadeh B, Seetharam AB, Cook MB, Wani S, Rastogi A, Bansal A, et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc 2012; 75: 236-41. 20.- Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2003; 58: S3-43. 21.- Sharma P, Bergman JJ, Goda K, Kato M, Messmann H, Alsop BR, et al. Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett’s Esophagus Using Narrow-Band Imaging. Gastroenterology 2016; 150: 591-8. Gastroenterol. latinoam 2016; Vol 27, Nº 3: 181-186
Gastro_3
To see the actual publication please follow the link above